Effectiveness of intravitreal aflibercept injections for anti-VEGF treatment-naive patients with diabetic macular edema in UK routine clinical practice (DRAKO): 12-month results

被引:0
|
作者
Sivaprasad, Sobha [1 ]
Ghanchi, Faruque [2 ]
Kelly, Simon P. [3 ]
Kotagiri, Ajay [4 ]
Talks, James S. [5 ]
Scanlon, Peter Henry [6 ]
Saddiq, Moneeb [7 ]
Napier, Jackie [8 ]
机构
[1] Moorfields Biomed Res Ctr, Natl Inst Hlth Res, London, England
[2] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England
[3] Bolton Hosp NHS Fdn Trust, Bolton, England
[4] South Tyneside & Sunderland NHS Fdn Trust, South Shields, England
[5] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[6] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England
[7] O4 Res Ltd, Belfast, Antrim, North Ireland
[8] Bayer PLC, Reading, Berks, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3294
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Assessing the effectiveness of intravitreal aflibercept in UK routine clinical practice for treatment-naive patients with diabetic macular edema: DRAKO 2-year results
    Ghanchi, Faruque
    Sivaprasad, Sobha
    Kelly, Simon
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    Saddiq, Moneeb
    Napier, Jackie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [2] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    EYE, 2022, 36 (01) : 64 - 71
  • [3] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    Eye, 2022, 36 : 64 - 71
  • [4] Evaluation of Intravitreal Aflibercept Treatment Effectiveness in UK Routine Clinical Practice for Patients with Diabetic Macular Edema: 24-month Outcomes of the DRAKO Study
    Talks, J.
    Sivaprasad, S.
    Kelly, S. P.
    Ghanchi, F.
    Kotagiri, A.
    Saddiq, M.
    Scanlon, P.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (1_SUPPL) : 7 - 8
  • [5] How effective is intravitreal aflibercept in routine clinical practice among treatment-naive patients with diabetic macular oedema? Year 1 results from DRAKO, a prospective, observational study conducted in the UK
    Talks, J.
    DIABETIC MEDICINE, 2022, 39
  • [6] Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
    Campos Polo, Rafael
    Rubio Sanchez, Consuelo
    Garcia Guisado, Diego Manuel
    Diaz Luque, Maria Jose
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 99 - 104
  • [7] Diabetic Macular Edema Treated With Intravitreal Aflibercept Injection After Treatment With Other Anti-VEGF Agents (SWAP-TWO Study)-12-Month Analysis
    Golshani, Cyrus
    Conti, Thais F.
    Conti, Felipe F.
    Silva, Fabiana Q.
    Rachitskaya, Aleksandra
    Yuan, Alex
    Schachat, Andrew
    Kaiser, Peter K.
    Singh, Rishi P.
    Babiuch, Amy
    JOURNAL OF VITREORETINAL DISEASES, 2020, 4 (05) : 364 - 371
  • [8] Real-life study assessing the effectiveness of intravitreal aflibercept injection (IAI) treatment of diabetic macular edema (DME) in UK routine clinical practice (DRAKO): Baseline Characteristics
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon
    Kotagiri, Ajay
    Talks, James S.
    Scanlon, Peter
    Saddiq, Moneeb
    Jain, Nitin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [9] Diabetic Macular Edema Treated with Intravitreal Aflibercept Injection After Treatment with Other Anti-VEGF Agents (SWAP-TWO Study)-12-month interim analysis
    Golshani, Cyrus
    Conti, Thais
    Conti, Felipe
    Silva, Fabiana Q.
    Rachitskaya, Aleksandra
    Yuan, Alex
    Schachat, Andrew
    Kaiser, Peter K.
    Singh, Rishi P.
    Babiuch, Amy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [10] Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice
    del Cura Mar, Prieto
    Carballes, Maria J. C.
    Sastre-Ibanez, Marina
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (08) : 3091 - 3094